Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 934-939

  Weinzimer, Stuart A ^a,c   Steil, Garry M ^b   Swan, Karena L ^a   Dziura, Jim ^a   Kurtz, Natalie ^b   Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDTRONIC INC   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL PANCREAS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERMETHOD COMPARISON; SENSOR; ALGORITHM; ARTIFICIAL ORGAN; AUTOMATION; BLOOD; CARBOHYDRATE DIET; EQUIPMENT DESIGN; HISTOLOGY; INSULIN INFUSION; PANCREAS; PANCREAS ISLET;

ADOLESCENT; ADULT; ALGORITHMS; ARTIFICIAL ORGANS; AUTOMATION; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; EQUIPMENT DESIGN; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN INFUSION SYSTEMS; ISLETS OF LANGERHANS; PANCREAS;

EID: 48649083317     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1967     Document Type: Article

References (23)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mel- litus. N Engl J Med 329:977-986, 1993
2. DCCT Research Group: The effects of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. J Pediatr 124:177-188, 1994
3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-2569, 2002
4. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159-2167, 2003
5. Bulsara MK, Holman CD, Davis EA, Jones TW: The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 10: 2293-2298, 2004
6. Rother KI, Harlan DM: Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 114: 877-883, 2004
7. Diabetes Research in Children Network (DirecNet) Study Group: Accuracy of the modified continuous glucose monitoring system (CGMS) sensor in an outpatient setting: results from a Diabetes Research in Children Network (DirecNet) study. Diabetes Technol Ther 7:109-114, 2005
8. Diabetes Research in Children Network (DirecNet) Study Group: Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 8:318-325, 2006
9. Hovorka R, Chassin LJ, Wilinska ME, Ca- nonico V, Akwi JA, Federici MO, Massi- Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR: Closing the loop: the ADICOL experience. Diabetes Technol Ther 6:307-318, 2004
10. Bequette BW: A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther 7:28-47, 2005
11. Hovorka R: Continuous glucose monitoring and closed-loop systems. Diabet Med 23:1-12, 2006
12. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 55:3344-3350, 2006
13. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV: Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. JClin En- docrinolMetab 72:277-282, 1991
14. Steil GM, Rebrin K, Janowski R, Darwin C, Saad F: Modeling β-cell insulin secretion: implications for closed-loop glucose homeostasis. Diabetes Technol Ther 5: 953-964, 2003
15. Steil GM, Panteleon AE, Rebrin K: Closed-loop insulin delivery: the path to physiological glucose control. Adv Drug Deliv Rev 56:125-144, 2004
16. Kollman C, WilsonDM, Wysocki T, Tam- borlane WV, Beck RW, Diabetes Research in Children Network (DirecNet) Study Group: Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. Diabetes Technol Ther 5:933-941, 2003
17. Swan KL, Weinzimer SA, Steil GM, Vos- kanyan GR, Dziura J, Steffen AT, Martin M, Tamborlane WV: Marked discordance between the time to peak plasma insulin concentrations and peak insulin action in pediatric patients utilizing continuous subcutaneous insulin infusion (Abstract). Diabetes 56 (Suppl. 1):A76, 2007
18. Ahren B: Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43:393410, 2000
19. Ahren B, Holst JJ: The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and non- cholinergic mechanisms and is important for postprandial glycemia. Diabetes 50: 1030-1038,2001
20. The Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System in children with type 1 diabetes. Diabetes Care30:59-64, 2007
21. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an im- plantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27:734-738, 2004
22. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a trans- cutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 29:44-50, 2006
23. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV: Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care 30: 1125-1130, 2007